The Latest Cardiac and Vascular News
SAN FRANCISCO, Sept. 14, 2021 /PRNewswire/ — Qardio, Inc. announced today the launch of the first ever fully remote end-to-end RPM service to include cardiac arrhythmia analysis. QardioDirect (Qardio’s all-inclusive service for RPM) now includes ambulatory Cardiac monitoring to help diagnose atrial fibrillation along with a large range of other arrhythmias. Multiple […]
MARLBOROUGH, Mass., September 14, 2021 – CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has entered into an agreement with IsoLase Ltd. to acquire IsoLase’s patent portfolio. The acquisition agreement includes US patents 8,992,514 and 10,517,669 and EU patent […]
The Company expands into exploration of its novel signal processing technology in physiologic pacing procedures Westport, CT, Sept. 13, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the […]
CARY, N.C. and BASEL, Switzerland, Sept. 13, 2021 /PRNewswire/ — Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases, presented an e-poster at the European Respiratory Society annual congress highlighting the protocol and design of the ongoing double-blind, placebo-controlled ELEVATE 2 (NCI NCT04712669) Phase 2b study of rodatristat ethyl (rodatristat) in patients […]
Japan’s first major leap toward digital therapeutics in the field of hypertension TOKYO–(BUSINESS WIRE)–The results of a Japanese Phase III domestic multicenter randomized controlled trial of a digital therapeutic app for hypertension (DTx) jointly developed by CureApp, Inc. (CEO Kohta Satake; hereafter “the Company”) and Jichi Medical University were presented […]
Data from the CERTITUDE Registry Presented at ESC 2021 LAKE OSWEGO, Ore., Sept. 9, 2021 /PRNewswire/ — Following the European Society of Cardiology (ESC) Congress 2021, BIOTRONIK today announced the first observational results of the CERTITUDE registry. The registry is designed to evaluate real-world clinical outcomes of patients in the United States who use implantable […]
An article published by the Heart Rhythm Society’s journal Heart Rhythm O2 concludes that Vektor’s Computational ECG Mapping System (vMap™) and protocol-based respiratory gating may help facilitate radioablation planning and maintain efficacy during therapy. CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc., a private company founded to develop the next-generation in arrhythmia mapping systems, today […]
Apabetalone, a First-in-Class Epigenetic Therapeutic Candidate, Met Key Endpoint of Lowering Pulmonary Vascular Resistance (PVR) and Was Well Tolerated Successful Completion and Promising Results of Investigator-led APPROACH-p Trial Sets the Stage for a Larger Multicenter Trial CALGARY, Alberta, Sept. 08, 2021 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) […]
BOSTON, Sept. 2, 2021 /PRNewswire/ — IDTechEx has recently launched the new version of their market research report on solid-state batteries – “Solid-State and Polymer Batteries 2021-2031: Technology, Forecasts, Players“. This report identifies key players within the market; discusses manufacturing challenges and how companies are addressing limitations; explores lithium metal as […]
MOUNTAIN VIEW, Calif., Sept. 1, 2021 /PRNewswire/ — AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services, today announced the KardiaMobile® 6L device was found to be superior to single lead devices according to results from the largest study to assess the reliability of the detection of atrial fibrillation (AF) through […]
